$191 Thousand is the total value of EADS & HEALD WEALTH MANAGEMENT's 142 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 23.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CHD | Buy | Church & Dwight | $2,577 | -8.6% | 28,123 | +0.0% | 1.35% | -2.4% |
| NEE | Buy | NextEra Energy | $1,753 | -0.6% | 30,603 | +28.7% | 0.92% | +6.1% |
| CAT | Buy | Caterpillar | $1,719 | +22.1% | 6,296 | +10.0% | 0.90% | +30.3% |
| BLL | Buy | Ball Corp. | $1,307 | -10.9% | 26,252 | +4.2% | 0.69% | -4.9% |
| LRCX | Buy | Lam Research | $1,303 | +11.3% | 2,079 | +14.1% | 0.68% | +18.6% |
| AVGO | Buy | Broadcom | $1,040 | +17.5% | 1,252 | +22.7% | 0.55% | +25.5% |
| STZ | Buy | Constellation Brands | $935 | +5.1% | 3,722 | +2.9% | 0.49% | +11.9% |
| CBRE | Buy | CBRE Group | $780 | -5.0% | 10,554 | +3.8% | 0.41% | +1.2% |
| VLO | Buy | Valero Energy Corp | $715 | +22.6% | 5,043 | +1.5% | 0.38% | +30.7% |
| CRL | Buy | Charles River Laboratories | $622 | +12.5% | 3,175 | +20.8% | 0.33% | +19.9% |
| CI | Buy | Cigna | $607 | +3.6% | 2,123 | +1.7% | 0.32% | +10.4% |
| RTX | Buy | Raytheon Technologies | $596 | -20.3% | 8,286 | +8.5% | 0.31% | -14.9% |
| ADSK | Buy | Autodesk | $583 | +3.9% | 2,818 | +2.8% | 0.31% | +10.9% |
| FCX | Buy | Freeport-McMoRan | $489 | +0.4% | 13,124 | +7.7% | 0.26% | +7.5% |
| OXY | Buy | Occidental Petroleum | $316 | +26.4% | 4,875 | +14.4% | 0.17% | +35.0% |
| BP | Buy | BP | $274 | +22.3% | 7,082 | +11.6% | 0.14% | +30.9% |
| CAG | New | ConAgra | $258 | – | 9,425 | +100.0% | 0.14% | – |
| DUK | Buy | Duke Energy | $258 | +1.6% | 2,922 | +3.2% | 0.14% | +8.0% |
| NFLX | New | Netflix | $225 | – | 597 | +100.0% | 0.12% | – |
| FITB | New | Fifth Third Bancorp | $206 | – | 8,135 | +100.0% | 0.11% | – |
| ATVI | New | Activision Blizzard | $203 | – | 2,171 | +100.0% | 0.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-10-27
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Thermo Fisher Scientific | 42 | Q3 2023 | 1.9% |
| Costco | 42 | Q3 2023 | 1.9% |
| Amazon.com | 42 | Q3 2023 | 2.2% |
| Apple | 42 | Q3 2023 | 2.1% |
| Stryker | 42 | Q3 2023 | 1.6% |
| Visa | 42 | Q3 2023 | 1.7% |
| Illinois Tool Works | 42 | Q3 2023 | 1.6% |
| Fiserv | 42 | Q3 2023 | 1.7% |
| Church & Dwight | 42 | Q3 2023 | 1.7% |
| PepsiCo | 42 | Q3 2023 | 1.6% |
View EADS & HEALD WEALTH MANAGEMENT's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-23 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-10-27 |
| 13F-HR | 2023-07-25 |
| 13F-HR | 2023-04-21 |
| 13F-HR | 2023-01-27 |
| 13F-HR | 2022-10-27 |
| 13F-HR | 2022-07-26 |
| 13F-HR | 2022-04-27 |
| 13F-HR | 2022-01-31 |
View EADS & HEALD WEALTH MANAGEMENT's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.